Equillium Inc (NASDAQ: EQ) shares gained 1.73%, or $0.1 per share, to close Thursday at $5.89. After opening the day at $5.80, shares of Equillium fluctuated between $5.95 and $5.66. 23,205 shares traded hands a decrease from their 30 day average of 67,795. Thursday’s activity brought Equillium’s market cap to $173,064,727.
Equillium is headquartered in La Jolla, California..
About Equillium Inc
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium is developing itolizumab for multiple severe immuno-inflammatory diseases, including acute graft-versus-host-disease (aGVHD), lupus/lupus nephritis and uncontrolled asthma.